Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Vehicle Designed For Blind To Take The Wheel
A student team in the Virginia Tech College of Engineering is providing the blind with an opportunity many never thought possible: The opportunity to drive.
buy viagra
Sosei And Vectura Announce Start Of Phase III Clinical Study With NVA237
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) and Vectura Group plc ("Vectura"; LSE: VEC) announce the commencement of a Phase III clinical study by Novartis, with NVA237, a once-daily, long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD). NVA237 is a dry powder formulation for oral inhalation of glycopyrronium bromide, a LAMA with a rapid onset of activity. The study has now appeared on clinicaltrials.gov and will be recruiting in the next few weeks when the first patient first visit will trigger a $7.5 million milestone payment to both Sosei and Vectura.
News of the day
IPS Examines Obstetric Fistula In Southern Senegal
Inter Press Service News Agency examines the prevalence of obstetric fistula in the southern region of Senegal. According to state reproductive health officials in the town of Kolda, 58 percent of births take place at home without medical assistance. "Women in the region suffer from exceptionally high rates of fistula," which "occurs when extended pressure damages the soft tissue in a woman"s pelvis during the process of giving birth" and can lead to debilitating complications and ostracization from their families, IPS writes.
Cardiovascular

Turner Syndrome Society Of The United States Announces Ambitious Goal To Crush Ignorance Of Turner Syndrome (TS)

The Turner Syndrome Society of the United States (TSSUS) recently concluded its 22nd Annual Conference in Portland, Oregon. The conference drew more than 350 individuals, families, researchers and health care professionals to network and learn about the latest research breakthroughs benefiting women and girls with TS. TSSUS continues to make great strides toward helping identify and assist those with TS. With that in mind the TSSUS board of directors met and unanimously agreed on setting an ambitious goal to Crush Ignorance of Turner Syndrome over the next decade. The TSSUS board also laid the groundwork for new fundraising, finance and public relations initiatives designed to professionalize the association and increase awareness of TS. One example: a board priority to "ensure that all short girls are evaluated for Turner syndrome will be advanced with a TSSUS produced brochure designed to promote this objective which will be mailed to all pediatricians in the US." "TSSUS continues to improve TS identification, outreach, and public relations efforts--now more important than ever, given economic conditions, competition for scarce res, and the current health care reform debate," said Cindy Dunnam, TSSUS executive director. "In spite of the climate of economic uncertainty the meeting was an economic success. More important was the boards" agreement on a clear direction and purpose for the Society over the next decade," continued Dunnam. "This speaks to the value of what TSSUS offers to those who are interested in helping those with Turner syndrome." The TSSUS 2010 meeting will be held in Indianapolis, Indiana at the Hyatt Regency, July 2nd-July 4th. See TSSUS" website for more information: http://www.turnersyndrome.org Turner Syndrome (TS) is a condition that affects only females - more than 75,000 in the United States alone. Main visible feature: short stature, usually below the 5th percentile of height in the female population. Early diagnosis and intervention is critical. If you already know about TS, tell a friend, family member, business associate or health care professional and help us Crush Ignorance of Turner Syndrome! We can"t do it without you. Turner Syndrome Society of the United States


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009